NSC |
Compound |
Enrichment |
Correlation |
NSC 163443 |
Null |
0.0490935610249067 |
0.13986301 |
NSC 173552 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.0490935610249067 |
0.20106436 |
NSC 269720 |
Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- |
0.0490935610249067 |
0.063766187 |
NSC 3077 |
s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) |
0.0490935610249067 |
0.10050089 |
NSC 328784 |
1-Piperazinecarboselenoic acid, 4-(2-pyridinyl)-, [1-(2-pyridinyl)ethylidene]hydrazide |
0.0490935610249067 |
0.13099717 |
NSC 339137 |
PHYSALOLACTONE |
0.0490935610249067 |
0.30280997 |
NSC 339579 |
7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate |
0.0490935610249067 |
0.23703067 |
NSC 342610 |
Null |
0.0490935610249067 |
0.11168447 |
NSC 372155 |
2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- |
0.0490935610249067 |
0.16984921 |
NSC 40618 |
Cyclohexanone, 2,6-dibenzylidene- (8CI) |
0.0490935610249067 |
0.51113175 |